Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1516096

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1516096

Bone Void Fillers Market - By Material Type, Form, Application, End-use - Global Forecast

PUBLISHED:
PAGES: 160 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

Bone void fillers market size is set to record 6.8% CAGR from 2024 to 2032, driven by the rising prevalence of orthopedic conditions and bone-related diseases, such as osteoporosis, arthritis, and bone fractures. As per WHO, around 350 million people worldwide have some kind of arthritis. The rise in number of older individuals susceptible to bone mass loss and fractures is necessitating effective orthopedic implants to facilitate healing. Advancements in medical technology are helping in developing more sophisticated biologically compatible materials to enhance bone regeneration and integration.

Rising surgical procedures due to trauma and sports injuries will also drive the market growth. As participation in sports and high-impact exercise is increasing, the incidence of orthopedic lesions requiring surgical intervention followed by bone filling will also surge. Rising supportive government policies and the increasing healthcare expenditures in emerging countries for expanding the availability of advanced orthopedic procedures will favor the product demand. The bone void fillers industry is segmented into material type, form, application, end-use, and region.

Based on material type, the market share from the calcium sulfate segment will record a decent growth rate between 2024 and 2032 due to its exceptional biocompatibility, resorbability, and ease of use in clinical settings. Calcium sulfate acts as a good scaffold for new bone growth for providing temporary retraction support when natural bone regenerate, reducing the need for a second operation to remove the filling on. Benefits of versatility, covering orthopedic, dental, and facial surgery will drive the product demand.

Bone void fillers industry from the granules form segment is anticipated to witness significant growth through 2024-2032 driven by its versatility, ease of application, and effectiveness in promoting bone regeneration. Granules offer a customizable solution for filling bone defects of different shapes and sizes, making them ideal for a wide range of orthopedic and dental treatments. With porous structure that allows blood vessels to permeate and promote the migration of osteoblasts, these granules have grown critical for new bone formation.

Asia Pacific bone void fillers industry size will record substantial growth through 2032, attributed to expanding healthcare infrastructure and expenditure along with the rising prevalence of bone-related ailments due to aging population. Rapid urbanization and industrialization in China and India have led to increased injury rates, further driving the demand for effective orthopedic restorative solutions. The growing medical tourism industry, especially in Thailand and Malaysia for offering advanced orthopedic services at affordable costs and attracting international patients will add to the regional market growth.

Product Code: 8861

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of bone disorders and injuries
      • 3.2.1.2 Rise in geriatric population
      • 3.2.1.3 Advancements in surgical techniques
      • 3.2.1.4 Growing orthopedic surgeries
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost associated with bone disorders
      • 3.2.2.2 Stringent regulatory scenario
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Material Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Demineralized bone matrix
  • 5.3 Calcium sulfate
  • 5.4 Collagen matrix
  • 5.5 Tricalcium phosphate
  • 5.6 Other material types

Chapter 6 Market Estimates and Forecast, By Form, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Gel
  • 6.3 Granules
  • 6.4 Paste
  • 6.5 Putty
  • 6.6 Other forms

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Spine fusion
  • 7.3 Bone fracture
  • 7.4 Joint reconstruction
  • 7.5 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Orthopedic clinics
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Abyrx, Inc.
  • 10.2 Baxter International Inc.
  • 10.3 Bioventus Inc.
  • 10.4 BONESUPPORT HOLDING AB
  • 10.5 Johnson & Johnson
  • 10.6 Medline Industries, Inc.
  • 10.7 Medtronic plc
  • 10.8 Stryker Corporation
  • 10.9 Wright Medical Group N.V.
  • 10.10 Zimmer Biomet Holdings, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!